Poland· PL-100341488
Tektrotyd
A 99mtc-technetium hynic-octreotid product containing hynic-[d-phe1,tyr3-octreotide] trifluoroacetate, registered in Poland by Narodowe Centrum Badań Jądrowych. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
99mtc-technetium hynic-octreotid is registered in 7 of 19 countries.
Countries holding a registration under ATC V09IA07 (99mtc-technetium hynic-octreotid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
99mtc-technetium hynic-octreotid · ATC V09IA07
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- HYNIC-[D-Phe1,Tyr3-octreotide] Trifluoroacetate
- Manufacturer
- Narodowe Centrum Badań Jądrowych
- Country
- Poland (PL)
- ATC code
- V09IA07
- ATC class
- 99mTc-Technetium hynic-octreotid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991295189
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09IA07
99mtc-technetium hynic-octreotid, as other registers publish it.
- Poland99mTc - TektrotydNarodowe Centrum Badań Jądrowych
- DenmarkTektrotydNarodowe Centrum Badan Jadrowych
- FinlandTektrotydNarodowe Centrum Badán Jadrowych
- CzechiaTEKTROTYDNarodowe Centrum Badań Jadrowych, Otwock
- NetherlandsTektrotyd 20 microgram kit voor radiofarmaceutisch preparaatNarodowe Centrum Badan Jadrowych
- BelgiumTektrotyd 20 µgNarodowe Centrum Badań Jądrowych PL
- SwitzerlandTektrotyd, Markierungsbesteckmedeo AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3532a9ea-de97-4889-bf7f-d91c456fb949 GET /v1/drugs/3532a9ea-de97-4889-bf7f-d91c456fb949?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zestaw do sporządzania preparatu radiofarmaceutycznego",
"source": "urpl",
"strength": "20 mcg",
"packaging": "05909991295189 ¦ Lz ¦ 117913\n1 zestaw (1 fiol. I + 1 fiol. II)",
"substance": "HYNIC-[D-Phe1,Tyr3-octreotidi] Trifluoroacetas 20 mcg",
"common_name": "HYNIC-[D-Phe1,Tyr3-octreotide] Trifluoroacetate",
"pl_product_id": "100341488",
"pozwolenie_nr": "23479",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about 99mtc-technetium hynic-octreotid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.